Myelodysplastic syndrome and immunotherapy novel to next in-line treatments

• Main Authors: Katherine Linder (Author), Premal Lulla (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Patients with Myelodysplastic syndromes (MDS) have few therapy options for sustainable responses in the frontline setting, and even less after hypomethylating agent (HMA) failure in relapsed and refractory setting. The only potential cure is an allogeneic hematopoietic stem cell transplant which is...